Skip to the page

Data / Form D filings / Scudo Biosciences Inc

Scudo Biosciences Inc: Form D filing

Scudo Biosciences Inc, a biotechnology company in San Diego, United States, filed a Form D with the SEC in 2025. The latest, on January 16, 2025, reports $50,000 sold of a $500,000 offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
11002 W OCEAN AIR DRIVE, #3122, San Diego, United States, 92130
Phone
(858) 305-6849
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2051096

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 16, 2025New notice$500,000$50,000$450,0001Jan 15, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Sheena McGowanExecutive Officer, Director
Ashley Maurice BuckleExecutive Officer, Director

Every Form D from the week of Jan 13, 2025 · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Scudo Biosciences Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.